Get the Stockscreener App
0.297
5.02%
0.0142
After Hours:
.29
-0.007
-2.36%
Bionano Genomics Inc stock is traded at $0.297, with a volume of 2.25M.
It is up +5.02% in the last 24 hours and down -35.38% over the past month.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.
See More
Previous Close:
$0.2828
Open:
$0.2851
24h Volume:
2.25M
Relative Volume:
1.12
Market Cap:
$28.48M
Revenue:
$36.12M
Net Income/Loss:
$-232.49M
P/E Ratio:
-0.0186
EPS:
-16.0015
Net Cash Flow:
$-126.87M
1W Performance:
-5.14%
1M Performance:
-35.38%
6M Performance:
-68.74%
1Y Performance:
-81.08%
1-Day Range:
$0.2801
$0.2989
1-Week Range:
$0.2626
$0.376
52-Week Range:
$0.2626
$2.27
Bionano Genomics Inc Stock (BNGO) Company Profile
Name
Bionano Genomics Inc
Sector
Industry
Phone
(858) 888-7600
Address
9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA
Bionano Genomics Inc Stock (BNGO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Dec-12-22 | Resumed | BTIG Research | Buy |
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
| Jun-16-21 | Initiated | BTIG Research | Buy |
| Sep-24-20 | Initiated | Ladenburg Thalmann | Buy |
| Apr-08-20 | Initiated | Oppenheimer | Outperform |
View All
Bionano Genomics Inc Stock (BNGO) Latest News
Optical Genome Mapping Market to Witness 26.76% CAGR During 2024-2030Consumables and Reagents to Register High GrowthBionano Genomics, Nucleome Informatics, and Praxis Genomics Dominate the Industry - Yahoo Canada Finance
Bionano Genomics Announces $3 Million Registered Direct OfferingSAN DIEGO, Oct. 31, 2024 – Bionano Genomics, Inc. (Nasdaq: BNGO) recently finalized a definitive agreement with institutional investors for a registered direct offering. The of - Defense World
Bionano Genomics stock hits 52-week low at $0.27 By Investing.com - Investing.com Australia
Bionano Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules - The Manila Times
Bionano Genomics stock hits 52-week low at $0.27 - Investing.com India
BNGOBionano Genomics, Inc. Latest Stock News & Market Updates - StockTitan
Bionano Announces $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules - The Manila Times
Bionano Adjourns Special Meeting of Stockholders to November 27, 2024 - The Manila Times
Bionano Genomics (STU:2Y30) Pre-Tax Income : €-189.69 Mil (TTM As of Jun. 2024) - GuruFocus.com
10 Best Penny Stocks to Invest in 2024 - Techopedia
Bionano Genomics' OGM outperforms in MYC gene study - Investing.com
Bionano Genomics' OGM outperforms in MYC gene study By Investing.com - Investing.com Canada
Bionano Announces Publication Outlining Utility of OGM for Resolution of MYC Gene Rearrangements in Multiple Myeloma - StockTitan
Analysts Predict How High Bionano Genomics Inc (BNGO) Will Go. - Stocks Register
Bionano Genomics stock hits 52-week low at $0.3 amid market challenges - Investing.com
Taking on analysts’ expectations and winning: Bionano Genomics Inc (BNGO) - SETE News
BNGO Stock: A Comprehensive Analysis and Forecast - The InvestChronicle
Bionano Genomics Inc (BNGO) deserves closer scrutiny - US Post News
Bionano Genomics Inc [BNGO] Stock trading around $0.37 per share: What’s Next? - The DBT News
Bionano Genomics Inc (BNGO) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle
Bionano Genomics reports lower Q3 revenue and cash reserves - Investing.com
Bionano Announces Preliminary 3Q 2024 Revenues and Cash - The Manila Times
Bionano Genomics reports lower Q3 revenue and cash reserves By Investing.com - Investing.com South Africa
Bionano Genomics, Inc. Revises Revenue Guidance for the Third Quarter Ended September 30, 2024 - Marketscreener.com
Bionano Genomics Inc (BNGO) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges ... - Yahoo Finance
Bionano Genomics Inc’s results are impressive - US Post News
Bionano Genomics Inc (BNGO)’s Market Momentum: Closing Strong at 0.46, Up 4.69 - The Dwinnex
Bionano Adjourns Special Meeting of Stockholders to October 30, 2024 - The Manila Times
Quarterly Metrics: Quick and Current Ratios for Bionano Genomics Inc (BNGO) - The Dwinnex
There is no way Bionano Genomics Inc (BNGO) can keep these numbers up - SETE News
A stock that deserves closer examination: Bionano Genomics Inc (BNGO) - US Post News
Short Interest in Bionano Genomics, Inc. (NASDAQ:BNGO) Grows By 13.0% - Defense World
Armistice Capital LLC Takes Position in Bionano Genomics, Inc. (NASDAQ:BNGO) - Defense World
Top investors say Bionano Genomics Inc (BNGO) ticks everything they need - SETE News
Do investors need to be concerned about Bionano Genomics Inc (BNGO)? - US Post News
Short Interest in Bionano Genomics, Inc. (NASDAQ:BNGO) Declines By 13.0% - Defense World
Bionano Genomics Inc (BNGO) Performance and Fundamentals Dashboard tells a completely different story - SETE News
Are Value Hunters Buying Bionano Genomics Inc (NASDAQ: BNGO) Stock? - Stocks Register
It would be worthwhile to take a closer look at Bionano Genomics Inc (BNGO) - US Post News
Bionano Genomics Inc (BNGO) Stock: From Low to High in 52 Weeks - The InvestChronicle
Ratios Reveal: Breaking Down Bionano Genomics Inc (BNGO)’s Financial Health - The Dwinnex
BTIG downgrades Bionano to Neutral after fourth workforce reduction - MSN
BTIG downgrades Bionano Genomics stock to Neutral amid workforce cuts By Investing.com - Investing.com Australia
BNGO News Today | Why did Bionano Genomics stock go down today? - MarketBeat
BTIG Downgrades Bionano Genomics (BNGO) - MSN
BioNano Genomics Restructures for Cost Efficiency and Cash Flow Optimization - TipRanks
Should investors be concerned about Bionano Genomics Inc (BNGO)? - US Post News
Bears are Losing Control Over Bionano Genomics (BNGO), Here's Why It's a 'Buy' Now - Zacks Investment Research
Bionano to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment Conference - StockTitan
Long Read Sequencing Market Innovations Investigated by Share Growth Status, Emerging Technology, Challenge... - WhaTech
Bionano Genomics, Inc. (NASDAQ:BNGO) Short Interest Update - Defense World
Bionano Genomics Inc Stock (BNGO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.98%
5.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):